Brokerages expect Walgreens Boots Alliance Inc (NASDAQ:WBA) to report earnings of $1.32 per share for the current fiscal quarter, according to Zacks. Eight analysts have provided estimates for Walgreens Boots Alliance’s earnings. The lowest EPS estimate is $1.29 and the highest is $1.39. Walgreens Boots Alliance posted earnings of $1.18 per share in the same quarter last year, which would indicate a positive year over year growth rate of 11.9%. The firm is expected to issue its next quarterly earnings results on Wednesday, July 5th.
On average, analysts expect that Walgreens Boots Alliance will report full year earnings of $5.01 per share for the current fiscal year, with EPS estimates ranging from $4.97 to $5.12. For the next year, analysts expect that the company will report earnings of $5.60 per share, with EPS estimates ranging from $5.50 to $5.83. Zacks Investment Research’s EPS calculations are an average based on a survey of sell-side analysts that cover Walgreens Boots Alliance.
Walgreens Boots Alliance (NASDAQ:WBA) last posted its earnings results on Wednesday, April 5th. The pharmacy operator reported $1.36 earnings per share for the quarter, hitting the consensus estimate of $1.36. The firm earned $29.45 billion during the quarter, compared to analysts’ expectations of $30.17 billion. Walgreens Boots Alliance had a return on equity of 16.76% and a net margin of 3.52%. The firm’s revenue was down 2.4% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.31 earnings per share.
WBA has been the topic of several recent analyst reports. Jefferies Group LLC reiterated a “buy” rating on shares of Walgreens Boots Alliance in a research report on Wednesday, December 21st. Deutsche Bank AG restated a “buy” rating and issued a $88.00 price objective on shares of Walgreens Boots Alliance in a report on Friday, January 6th. Leerink Swann set a $90.00 price objective on Walgreens Boots Alliance and gave the stock a “buy” rating in a report on Sunday, January 8th. Zacks Investment Research upgraded Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $94.00 price objective on the stock in a report on Tuesday, January 17th. Finally, Robert W. Baird restated an “outperform” rating on shares of Walgreens Boots Alliance in a report on Tuesday, January 24th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and eleven have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $91.77.
Walgreens Boots Alliance (NASDAQ:WBA) traded up 0.79% during midday trading on Wednesday, reaching $83.13. The company had a trading volume of 1,931,626 shares. The firm’s 50-day moving average price is $84.22 and its 200 day moving average price is $83.19. Walgreens Boots Alliance has a 12 month low of $75.74 and a 12 month high of $88.00. The firm has a market capitalization of $89.86 billion, a PE ratio of 21.37 and a beta of 1.20. Walgreens Boots Alliance also was the recipient of unusually large options trading on Monday. Stock traders acquired 696 put options on the stock. This represents an increase of 300% compared to the average volume of 174 put options.
In related news, COO Ornella Barra bought 124,000 shares of the stock in a transaction dated Tuesday, February 7th. The stock was acquired at an average price of $80.93 per share, for a total transaction of $10,035,320.00. Following the completion of the purchase, the chief operating officer now owns 1,690,336 shares in the company, valued at $136,798,892.48. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Janice M. Babiak bought 600 shares of the stock in a transaction dated Thursday, February 2nd. The stock was bought at an average price of $80.68 per share, with a total value of $48,408.00. Following the purchase, the director now owns 600 shares of the company’s stock, valued at approximately $48,408. The disclosure for this purchase can be found here. 13.50% of the stock is currently owned by company insiders.
Several large investors have recently bought and sold shares of WBA. Mascoma Wealth Management LLC bought a new stake in Walgreens Boots Alliance during the fourth quarter worth about $111,000. Orrstown Financial Services Inc. raised its stake in shares of Walgreens Boots Alliance by 13.9% in the first quarter. Orrstown Financial Services Inc. now owns 1,515 shares of the pharmacy operator’s stock worth $126,000 after buying an additional 185 shares during the period. Parasol Investment Management LLC raised its stake in shares of Walgreens Boots Alliance by 3.5% in the third quarter. Parasol Investment Management LLC now owns 1,787 shares of the pharmacy operator’s stock worth $144,000 after buying an additional 60 shares during the period. Genovese Burford & Brothers Wealth & Retirement Plan Management LLC raised its stake in shares of Walgreens Boots Alliance by 8,176.0% in the fourth quarter. Genovese Burford & Brothers Wealth & Retirement Plan Management LLC now owns 149,961 shares of the pharmacy operator’s stock worth $150,000 after buying an additional 148,149 shares during the period. Finally, Exane Derivatives raised its stake in shares of Walgreens Boots Alliance by 56.3% in the third quarter. Exane Derivatives now owns 1,884 shares of the pharmacy operator’s stock worth $152,000 after buying an additional 679 shares during the period. Institutional investors and hedge funds own 59.98% of the company’s stock.
WARNING: This piece of content was reported by Community Financial News and is the property of of Community Financial News. If you are accessing this piece of content on another domain, it was copied illegally and reposted in violation of US and international copyright and trademark legislation. The original version of this piece of content can be viewed at https://www.com-unik.info/2017/05/17/analysts-expect-walgreens-boots-alliance-inc-wba-to-announce-1-32-earnings-per-share-updated-updated-updated.html.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
For more information about research offerings from Zacks Investment Research, visit Zacks.com
What are top analysts saying about Walgreens Boots Alliance Inc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Walgreens Boots Alliance Inc and related companies.